[Experimental and clinical study of a new non-steroidal anti-inflammatory agent: butoxyphenylacetylhydroxamic acid (Droxaryl)].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D007022:Hypotension / Q000139:chemically induced; D010003:Osteoarthritis / Q000188:drug therapy*; D051381:Rats; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists; D006877:Hydroxamic Acids; D002351:Carrageenan
Etude experimentale et clinique d'un nouvel anti-inflammatoire non stéroïdien: l'acide butoxyphénylacéthydroxamique (Droxaryl)